Patents by Inventor Ulrich Walker

Ulrich Walker has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Mitochondrial nucleic acid as a marker for autoimmune and autoinflammatory diseases
    Patent number: 9631235
    Abstract: The present invention relates to a method for increasing the diagnostic likelihood of the presence or absence of, or monitoring the progression or activity of an inflammatory autoimmune disease (AID), comprising detecting mitochondrial NA (e.g. mtDNA) in a sample from an individual suffering from the AID or suspected of suffering from the AID.
    Type: Grant
    Filed: April 30, 2012
    Date of Patent: April 25, 2017
    Assignee: Universitaetsklinikum Freiburg
    Inventors: Ulrich Walker, Dirk Lebrecht, Nils Venhoff
  • MITOCHONDRIAL NUCLEIC ACID AS A MARKER FOR AUTOIMMUNE AND AUTOINFLAMMATORY DISEASES
    Publication number: 20140099648
    Abstract: The present invention relates to a method for increasing the diagnostic likelihood of the presence or absence of, or monitoring the progression or activity of an inflammatory autoimmune disease (AID), comprising detecting mitochondrial NA (e.g. mtDNA) in a sample from an individual suffering from the AID or suspected of suffering from the AID.
    Type: Application
    Filed: April 30, 2012
    Publication date: April 10, 2014
    Applicant: Universitaetsklinikum Freiburg
    Inventors: Ulrich Walker, Dirk Lebrecht, Nils Venhoff
  • Combating side-effects
    Patent number: 6992072
    Abstract: The invention relates to the use of active ingredients, which increase the concentration of pyrimidine-based elements for nucleic acid biosynthesis in the body, in particular to the use of pyrimidine nucleosides and/or prodrugs produced therefrom, for reducing the side-effects of inhibitors of nucleic acid biosynthesis or their precursors, in particular by activating the biosynthesis of mitochondrial DNA (mtDNA). The invention also relates to the use of said active ingredients, in particular pyrimidine nucleosides and/or prodrugs for producing pharmaceutical preparations for reducing the aforementioned side-effects and to combinations or products for administering active ingredients of this type, in particular pyrimidine nucleosides and/or prodrugs produced therefrom, comprising inhibitors of nucleic acid biosynthesis or their precursors.
    Type: Grant
    Filed: February 27, 2002
    Date of Patent: January 31, 2006
    Assignee: Pharma Nord ApS
    Inventor: Ulrich Walker
  • Combating side-effects
    Publication number: 20040138157
    Abstract: The invention relates to the use of active ingredients, which increase the concentration of pyrimidine-based elements for nucleic acid biosynthesis in the body, in particular to the use of pyrimidine nucleosides and/or prodrugs produced therefrom, for reducing the side-effects of inhibitors of nucleic acid biosynthesis or their precursors, in particular by activating the biosynthesis of mitochondrial DNA (mtDNA). The invention also relates to the use of said active ingredients, in particular pyrimidine nucleosides and/or prodrugs for producing pharmaceutical preparations for reducing the aforementioned side-effects and to combinations or products for administering active ingredients of this type, in particular pyrimidine nucleosides and/or prodrugs produced therefrom, comprising inhibitors of nucleic acid biosynthesis or their precursors.
    Type: Application
    Filed: February 11, 2004
    Publication date: July 15, 2004
    Inventor: Ulrich Walker